Skip to main content
. 2020 Mar;8(5):206. doi: 10.21037/atm.2020.01.57

Table 2. Culprit artery, lesion and procedural indices.

Selected indices Non-COPD COPD P value
TASC II (18), % 0.02CA
   A 19.7 17
   B 21.3 11
   C 15.7 11
   D 43.3 61
Angiography—first access site, % 0.01P
   Brachial 3 8.2
   Femoral 73 62.9
   Radial 24 28.9
Angiography—number of access sites, % 0.21CA
   1 82.3 76.5
   2 16.2 21.4
   3 1.2 2.1
   4 0.3 0
Angiography—first access side, % 65.2 72.4 0.15P
   Right
   Left 34.8 27.6
Iliac artery—significant lesion, % 11.5 20.4 0.01P
Deep femoral artery—significant lesion, % 4.8 6.1 0.61F
Common femoral artery
   Tortuosity 0.22F
      Slight 5.6 1.5
      No 94.4 98.5
   Chronic total occlusion 3.5 7.5 0.16F
   Calcification 0.93CA
      No 46.4 46.3
      Slight 37.8 38.8
      Severe 15.8 14.9
   Lesion length, mm 13.4±14.6 18.5±21.9 0.1U
Superficial femoral artery
   Tortuosity 0.54CA
      Severe 2.5 4.3
      Slight 35.1 28
      No 62.4 67.7
   Chronic total occlusion 49.9 48.4 0.78P
   Calcification 0.67CA
      Extreme 3.3 2.1
      Severe 43.8 41.9
      Slight 35.3 38.7
      No 17.6 17.3
   Lesion length, mm 124.5±108.9 152.5±118.3 0.02U
Popliteal artery—lesion length, mm 51.9±48.5 55.4±49.6 0.56U
Lesion location in crural arteries, %
   Tibio-fibular trunk 24.1 29.6 0.23P
   Tibialis anterior artery 46 50 0.45P
   Peroneal artery 35.8 42.3 0.21P
   Tibialis posterior artery 47.4 48 0.91P
Fluoroscopy time, s 846.6±712.6 682.4±578.2 0.25U
Contrast volume, mL 119±83.6 134.6±90.5 0.11U
Time from procedure to discharge, days 3.63±2.31 2.25±0.5 0.33U
Hospitalization time, days 5.22±4.95 7.44±7.44 0.008U
Intraprocedural complications, % 6 1 0.04P
Major vascular complications, % 3.3 7.1 0.08F
Minor vascular complications, % 13.5 9.2 0.23P

CA, Cochran-Armitage test for trend; F, Fisher’s exact test; P, Pearson’s chi-squared test; TASC, Trans-Atlantic Inter Society Consensus; U, Mann-Whitney U test.